At a glance

The Zur Rose Group in 2022 in facts and figures.


National roll-out of e-prescriptions started in Germany


EBITDA improvement (adjusted) in CHF


Funds raised for refinancing and general corporate purposes in CHF


Percentage of women on the Board of Directors – target reached a year ahead of schedule

New logistics

Automation level increased in Heerlen to 70 per cent and capacity more than doubled to 27 million packages per year


medpex brand successfully integrated at the Heerlen location and the Eurapon brand discontinued


Second year of reporting focused on setting targets, optimised governance structure, carbon footprint, diversity and inclusion


Significant growth in Switzerland

This site uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. For more information, please see our cookie statement.